Model selection in measures of vascular parameters using dynamic contrast-enhanced MRI: experimental and clinical applications
about
Peritumoral tissue compression is predictive of exudate flux in a rat model of cerebral tumor: an MRI study in an embedded tumor.Are complex DCE-MRI models supported by clinical data?Intratumor distribution and test-retest comparisons of physiological parameters quantified by dynamic contrast-enhanced MRI in rat U251 gliomaCilengitide-induced temporal variations in transvascular transfer parameters of tumor vasculature in a rat glioma model: identifying potential MRI biomarkers of acute effects.Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.A quantitative MRI method for imaging blood-brain barrier leakage in experimental traumatic brain injuryROCKETSHIP: a flexible and modular software tool for the planning, processing and analysis of dynamic MRI studies.US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers.Cell Treatment for Stroke in Type Two Diabetic Rats Improves Vascular Permeability Measured by MRI.Comparison of Cerebral Blood Volume and Plasma Volume in Untreated Intracranial Tumors.Effect of T2* correction on contrast kinetic model analysis using a reference tissue arterial input function at 7 T.Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRICombination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma.Targeting Bone Marrow to Potentiate the Anti-Tumor Effect of Tyrosine Kinase Inhibitor in Preclinical Rat Model of Human Glioblastoma.Models and methods for analyzing DCE-MRI: a review.Quantitative Gd-DOTA uptake from cerebrospinal fluid into rat brain using 3D VFA-SPGR at 9.4T.Acute Temporal Changes of MRI-Tracked Tumor Vascular Parameters after Combined Anti-angiogenic and Radiation Treatments in a Rat Glioma Model: Identifying Signatures of Synergism.Simultaneous measurement of T1 /B1 and pharmacokinetic model parameters using active contrast encoding (ACE)-MRI.DCE-MRI prediction of survival time for patients with glioblastoma multiforme: using an adaptive neuro-fuzzy-based model and nested model selection technique.Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications.An adaptive model for rapid and direct estimation of extravascular extracellular space in dynamic contrast enhanced MRI studies.Pseudo-extravasation rate constant of dynamic susceptibility contrast-MRI determined from pharmacokinetic first principles.Joint arterial input function and tracer kinetic parameter estimation from undersampled dynamic contrast-enhanced MRI using a model consistency constraint.Molecular imaging and fusion targeted biopsy of the prostate.An extended vascular model for less biased estimation of permeability parameters in DCE-T1 images.Chronic global analysis of vascular permeability and cerebral blood flow after bone marrow stromal cell treatment of traumatic brain injury in the rat: A long-term MRI study.Magnetic Resonance Imaging in Experimental Traumatic Brain Injury.Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.Toward a noninvasive estimate of interstitial fluid pressure by dynamic contrast-enhanced MRI in a rat model of cerebral tumor.Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI.MRI investigation of glymphatic responses to Gd-DTPA infusion rates
P2860
Q30680915-5513E376-3D52-4AF6-A3B6-352FF83409CBQ31053409-DF6CFB01-9277-444F-A291-EA26D8A1F447Q34160869-79C50B83-3CFB-4417-B03D-403F7888FE0AQ35078406-730C129E-8793-48C2-92D0-7FC3DFE98924Q35402503-C017762C-FB73-4897-BBF1-C5ED65D1F7B8Q35493651-BE7C3399-6C7B-4555-BD5C-525DE2B1B7D7Q35664458-696D90DF-1828-466C-A11A-5B94B3F26098Q35911336-94180915-4A81-481D-9B57-5208137BA811Q35930448-3211C902-1BDB-4CD3-9C5F-08DC371FF343Q36120153-B70AC885-33CA-42AD-AD6E-FBD56F29B739Q36315028-D26A657F-8EF8-44A3-A481-5C8C876A4D46Q36501363-89CB849B-A794-4372-B766-B34FFE182B1CQ36684023-7B2B02E5-97D0-41FE-8F75-E13502EB61E6Q37095230-53529A77-46FC-4BBB-9D35-7B5DE20314B9Q38282639-CCF12DB4-02B8-43F9-93BC-10F54FCD732DQ38669561-30BD6311-73F2-46E9-B139-D9DBC995EA98Q38724990-225E3273-660E-42BF-912C-7154D3D9E9C1Q38764089-7499874A-DDB4-4EAC-B16F-4B90321CE161Q38764240-C7ABC525-9E63-4CA2-B832-CB05F13EB78EQ38822172-231FC316-A07E-4B49-B31B-3504610C61A6Q38962380-8CD36EEC-10C9-4FA7-8802-0E415BC1BC23Q40051044-4EEDDC50-3A85-485C-82E2-9686D6944863Q46028234-260BA209-3A4D-461C-ADF0-38F8EDEF87FAQ47608215-29B98D7D-D7FF-4DBA-997C-0725E3B8712BQ47968080-0DB00382-352D-46A2-AF5C-8182F1600354Q47995142-50A73AA2-0AD8-4A09-B234-9D1DDE3F57BBQ48041548-49ABD288-F8BC-44A4-8B8D-F09B4DD03B31Q52654441-0A796994-F5CD-4B51-A8F7-77E6B4C43154Q52663342-085E484D-9CFD-4FFE-80A3-A8F37A8035DEQ52986134-EF818DA9-5149-4485-97AF-C9C1241DB5AAQ53032280-DDFA7291-6C0B-4FD6-A32B-058F7A33EC9EQ57113738-F846318C-6B6D-4744-9A37-40808452B6B4
P2860
Model selection in measures of vascular parameters using dynamic contrast-enhanced MRI: experimental and clinical applications
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Model selection in measures of ...... ntal and clinical applications
@ast
Model selection in measures of ...... ntal and clinical applications
@en
Model selection in measures of ...... ntal and clinical applications
@nl
type
label
Model selection in measures of ...... ntal and clinical applications
@ast
Model selection in measures of ...... ntal and clinical applications
@en
Model selection in measures of ...... ntal and clinical applications
@nl
prefLabel
Model selection in measures of ...... ntal and clinical applications
@ast
Model selection in measures of ...... ntal and clinical applications
@en
Model selection in measures of ...... ntal and clinical applications
@nl
P2860
P3181
P356
P1433
P1476
Model selection in measures of ...... ntal and clinical applications
@en
P2093
Hassan Bagher-Ebadian
James R. Ewing
P2860
P304
P3181
P356
10.1002/NBM.2996
P407
P577
2013-08-01T00:00:00Z